Lyell Immunopharma近日宣布,该公司已正式启动一项3期头对头CAR-T细胞疗法临床试验,该试验专门针对侵袭性大B细胞淋巴瘤患者。与此同时,公司还宣布成立了专家指导委员会,为这一重要临床研究提供专业指导。
Lyell Immunopharma近日宣布,该公司已正式启动一项3期头对头CAR-T细胞疗法临床试验,该试验专门针对侵袭性大B细胞淋巴瘤患者。与此同时,公司还宣布成立了专家指导委员会,为这一重要临床研究提供专业指导。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.